RARE INSIGHTS |
Making the RARE voice heard
The International Network of Paediatric Surveillance Units (INOPSU) is due to hold its 10th scientific conference in Glasgow, Scotland at the SEC Centre on Tuesday 13th March 2018. The conference will be held as a satellite session of the Royal College of Paediatrics and Child Health annual meeting. The conference will explore paediatric rare disease surveillance and its global impact on public health and clinical practice.  Register Cutting edge scientific data will be presented from world leading clinicians, scientists and policy-makers. Presentations will consider the central role paediatric surveillance has played in addressing infectious diseases and other conditions. Presentations will consider variant CJD; the primacy of international collaborations on understanding the natural history of rare diseases; the continued importance of monitoring emerging and re-emerging diseases such as E. coli. O157; and more! Places are limited so make sure you reserve your place. Speakers include: A key note speach will be received from Professor Rob Will, Director of the National CJD Surveillance Unit. Presentations will also be received from, Dr Alison Smith-Palmer, Health Protection Scotland; Dr Chris Verity, Addenbrookes Hospital; Dr Michael Flavin, Queen’s University, Canada; Professor Yvonne Zurynski, Australian Paediatric Surveillance Unit and Dr Mirjam Mäusezahl-Feuz, Chair of INOPSU amongst others. Topics include: Neonatal meningitis; Group b strep; UK vaccination programme; Kawasaki disease; sepsis; E.coli; type 2 diabetes; rickets; FGM and others. Further information Dr Richard Reading, Chair, BPSU Scientific Committee
BPSU, Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London, WC1X 8SH Tel. +44 (0) 20 7092 6174 Email: BPSU.OrangeCard@rcpch.ac.uk Dr Mirjam Mäusezahl-Feuz, Chair of INOPSU Eidgenössisches Departement des Innern EDI Bundesamt für Gesundheit BAG Abteilung Übertragbare Krankheiten Schwarztorstrasse 96, CH-3003 Bern Tel. +41 058 463 8758
0 Comments
Leave a Reply. |
